ebomi
Colour theme
Sign in
Insider · CIK 0001681643

Zoghbi Huda Y

CIK 0001681643 Name as filed on the most recent filing

Filed as Zoghbi Huda Y (9)

34 transaction lines · from 9 filings · filed 2020-05-08 to 2026-08-12 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-21 05:23 UTC.

No issuer is recorded

The catalog holds no filing linking this CIK to an issuer.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

34 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-21 05:23 UTC.

Transactions filed by this insider
Direction Date Issuer Code Shares Price Value USD Filing
2026-08-10 Regeneron Pharmaceuticals, Inc.
REGN 		S, Open-market sale 800 disposed 800.00 640,000.00 Form 4, filing 0001681643-26-000006
2026-02-19 Regeneron Pharmaceuticals, Inc.
REGN 		S, Open-market sale 331 disposed 780.45 258,328.95 Form 4, filing 0001681643-26-000004
2026-02-19 Regeneron Pharmaceuticals, Inc.
REGN 		S, Open-market sale 298 disposed 782.10 233,065.80 Form 4, filing 0001681643-26-000004
2026-02-19 Regeneron Pharmaceuticals, Inc.
REGN 		S, Open-market sale 220 disposed 783.29 172,323.80 Form 4, filing 0001681643-26-000004
2026-02-19 Regeneron Pharmaceuticals, Inc.
REGN 		S, Open-market sale 209 disposed 781.28 163,287.52 Form 4, filing 0001681643-26-000004
2026-02-19 Regeneron Pharmaceuticals, Inc.
REGN 		S, Open-market sale 208 disposed 779.55 162,146.40 Form 4, filing 0001681643-26-000004
2026-02-19 Regeneron Pharmaceuticals, Inc.
REGN 		S, Open-market sale 160 disposed 784.45 125,512.00 Form 4, filing 0001681643-26-000004
2026-02-19 Regeneron Pharmaceuticals, Inc.
REGN 		S, Open-market sale 56 disposed 785.61 43,994.16 Form 4, filing 0001681643-26-000004
2026-02-19 Regeneron Pharmaceuticals, Inc.
REGN 		S, Open-market sale 53 disposed 778.47 41,258.91 Form 4, filing 0001681643-26-000004
2026-02-19 Regeneron Pharmaceuticals, Inc.
REGN 		S, Open-market sale 50 disposed 775.50 38,775.00 Form 4, filing 0001681643-26-000004
2026-02-19 Regeneron Pharmaceuticals, Inc.
REGN 		S, Open-market sale 49 disposed 774.68 37,959.32 Form 4, filing 0001681643-26-000004
2026-02-19 Regeneron Pharmaceuticals, Inc.
REGN 		S, Open-market sale 4 disposed 790.00 3,160.00 Form 4, filing 0001681643-26-000004
2024-01-02 Regeneron Pharmaceuticals, Inc.
REGN 		S, Open-market sale 1,117 disposed 900.00 1,005,300.00 Form 4, filing 0001968202-24-000028
2023-10-13 Regeneron Pharmaceuticals, Inc.
REGN 		S, Open-market sale 1,000 disposed 850.00 850,000.00 Form 4, filing 0001968202-23-000037
2022-03-16 Regeneron Pharmaceuticals, Inc.
REGN 		S, Open-market sale 2,000 disposed 675.00 1,350,000.00 Form 4, filing 0001708138-22-000024
2021-09-14 Regeneron Pharmaceuticals, Inc.
REGN 		S, Open-market sale 998 disposed 650.00 648,700.00 Form 4, filing 0001708138-21-000081
2021-09-13 Regeneron Pharmaceuticals, Inc.
REGN 		S, Open-market sale 2 disposed 651.10 1,302.20 Form 4, filing 0001708138-21-000081
2020-07-07 Regeneron Pharmaceuticals, Inc.
REGN 		S, Open-market sale 1,706 disposed 650.00 1,108,900.00 Form 4, filing 0001237899-20-000028
2020-06-11 Regeneron Pharmaceuticals, Inc.
REGN 		S, Open-market sale 1,706 disposed 625.00 1,066,250.00 Form 4, filing 0001708138-20-000072
2020-06-10 Regeneron Pharmaceuticals, Inc.
REGN 		S, Open-market sale 330 disposed 608.62 200,844.60 Form 4, filing 0001708138-20-000072
2020-06-10 Regeneron Pharmaceuticals, Inc.
REGN 		S, Open-market sale 265 disposed 612.52 162,317.80 Form 4, filing 0001708138-20-000072
2020-06-10 Regeneron Pharmaceuticals, Inc.
REGN 		S, Open-market sale 251 disposed 607.64 152,517.64 Form 4, filing 0001708138-20-000072
2020-06-10 Regeneron Pharmaceuticals, Inc.
REGN 		S, Open-market sale 202 disposed 610.41 123,302.82 Form 4, filing 0001708138-20-000072
2020-06-10 Regeneron Pharmaceuticals, Inc.
REGN 		S, Open-market sale 164 disposed 611.46 100,279.44 Form 4, filing 0001708138-20-000072
2020-06-10 Regeneron Pharmaceuticals, Inc.
REGN 		S, Open-market sale 161 disposed 609.48 98,126.28 Form 4, filing 0001708138-20-000072
2020-06-10 Regeneron Pharmaceuticals, Inc.
REGN 		S, Open-market sale 149 disposed 606.64 90,389.36 Form 4, filing 0001708138-20-000072
2020-06-10 Regeneron Pharmaceuticals, Inc.
REGN 		S, Open-market sale 99 disposed 616.19 61,002.81 Form 4, filing 0001708138-20-000072
2020-06-10 Regeneron Pharmaceuticals, Inc.
REGN 		S, Open-market sale 80 disposed 615.28 49,222.40 Form 4, filing 0001708138-20-000072
2020-06-10 Regeneron Pharmaceuticals, Inc.
REGN 		S, Open-market sale 5 disposed 613.03 3,065.15 Form 4, filing 0001708138-20-000072
2020-05-07 Regeneron Pharmaceuticals, Inc.
REGN 		S, Open-market sale 2,128 disposed 566.37 1,205,235.36 Form 4, filing 0001708138-20-000050
2020-05-07 Regeneron Pharmaceuticals, Inc.
REGN 		S, Open-market sale 1,722 disposed 565.64 974,032.08 Form 4, filing 0001708138-20-000050
2020-05-07 Regeneron Pharmaceuticals, Inc.
REGN 		S, Open-market sale 646 disposed 567.58 366,656.68 Form 4, filing 0001708138-20-000050
2020-05-07 Regeneron Pharmaceuticals, Inc.
REGN 		S, Open-market sale 609 disposed 568.37 346,137.33 Form 4, filing 0001708138-20-000050
2020-05-07 Regeneron Pharmaceuticals, Inc.
REGN 		S, Open-market sale 13 disposed 569.20 7,399.60 Form 4, filing 0001708138-20-000050

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Search the catalog
Codes on this page
S, Open-market sale
Open-market sale

Every value is as reported on the Form 4. A price the filing did not report is marked Not reported and no value is computed from it. Codes outside the open market, drawn in grey behind a dashed rule, are compensation and administrative machinery rather than a decision to trade at the prevailing price.

What this insider's stored lines contain

Exact counts over every stored line for this entity. This is a statement of composition, not a filter: the only filter this page offers is the open-market one above, because that is the only one an index serves today.

  • Open-market purchase 0
  • Open-market sale 34
  • Option exercise 0
  • Grant or award 0
  • Tax withholding 0
  • Disposition to the issuer 0
  • In-the-money option exercise 0

How to cite this page

ebomi catalog. Zoghbi Huda Y, insider transactions. Retrieved 2026-08-21 from https://ebomi.com/insider/0001681643

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.